To the full analysis
Ascopiave stock: growth
ASC.MIAscopiave reported $270.73M in revenue for fiscal 2025, up 19.2% on the prior year, up 8.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−1.4%
per year from 2006 to 2025, per share −1%
Earnings (Annual rate)
9.2%
per year from 2006 to 2025, per share 7%
Free cash flow (Annual rate)
9.5%
per year from 2006 to 2025, per share 10%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 8.3% | −8.3% | −1.4% |
| Revenue per share | 8.9% | −8.1% | −1.0% |
| Earnings | 8.1% | 7.3% | 9.2% |
| Earnings per share | 9.0% | 7.7% | 7.0% |
| Free cash flow | no data | 9.2% | 9.5% |
| Free cash flow per share | no data | 9.5% | 10.0% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $352.49M | $17.99M | $22.41M |
| 2007 | $500.72M | $24.52M | −$113.47M |
| 2008 | $913.82M | $20.82M | $126.64M |
| 2009 | $846.76M | $28.69M | $4.22M |
| 2010 | $948.41M | $36.4M | $3.72M |
| 2011 | $1.22B | $9.15M | −$42.72M |
| 2012 | $1.19B | $30.88M | $24.58M |
| 2013 | $946.69M | $42.86M | $82.78M |
| 2014 | $648.57M | $39.43M | $38.89M |
| 2015 | $644.53M | $47.66M | $52.31M |
| 2016 | $551.49M | $59.43M | $52.77M |
| 2017 | $590.39M | $52.23M | $29.88M |
| 2018 | $644.53M | $49.45M | $43.38M |
| 2019 | $138.41M | $16.04M | −$18.86M |
| 2020 | $181.61M | $65.05M | −$2.52M |
| 2021 | $149.49M | $50.23M | −$2.52M |
| 2022 | $181.34M | $36.19M | $12.88M |
| 2023 | $200.34M | $40.09M | −$90.25M |
| 2024 | $227.11M | $39.7M | $22.29M |
| 2025 | $270.73M | $96.23M | $126.47M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 15 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.